Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
International Journal of Medical Informatics|December 7, 2002
Guideline and quality indicators for development, purchase and use of controlled health vocabulariesPeter L Elkin, Steven H Brown, John Carter, et al.Studies in Health Technology and Informatics|December 11, 2003
Data representation in healthcare: a design for a freely-available openly-developed international reference terminology for healthcarePeter L Elkin, Steven H Brown, Michael J Lincoln, et al.Journal of the American Academy of Dermatology|January 5, 2002
Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous LymphomasEric C Vonderheid, Maria Grazia Bernengo, Günter Burg, et al.Breast Cancer Research and Treatment|August 2, 2003
A phase II study of topical ceramides for cutaneous breast cancerAminah Jatoi, Vera J Suman, Paul Schaefer, et al.The American Journal of Hospice & Palliative Care|January 4, 2019
Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case SeriesJennifer G Le-Rademacher, Kendrith Rowland, Pamela J Atherton, et al.Experimental Dermatology|June 16, 2016
Monopathogenic vs multipathogenic explanations of pemphigus pathophysiologyA Razzaque Ahmed, Marco Carrozzo, Frédéric Caux, et al.Blood|June 2, 2007
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Elise Olsen, Eric Vonderheid, Nicola Pimpinelli, et al.Journal of the American Academy of Dermatology|December 15, 2010
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)Elise A Olsen, Alain H Rook, John Zic, et al.The Journal of Investigative Dermatology|February 28, 2024
Topical Ruxolitinib in the Treatment of Necrobiosis Lipoidica: A Prospective, Open-Label StudyAngelina S Hwang, Jacob A Kechter, Xing Li, et al.Blood|November 10, 2021
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCElise A Olsen, Sean Whittaker, Rein Willemze, et al.Pageof 3